title: Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency.
authors.affiliation: Ali Ebn-e Abitaleb Hospital Research Center for Adolescents Health, Zahedan University of Medical Sciences, Zahedan, Iran.
authors.forename: M
authors.initials: M
authors.lastname: Naderi
authors.forename: A
authors.initials: A
authors.lastname: Dorgalaleh
authors.forename: S
authors.initials: S
authors.lastname: Alizadeh
authors.forename: Z
authors.initials: Z
authors.lastname: Kashani Khatib
authors.forename: S
authors.initials: S
authors.lastname: Tabibian
authors.forename: A
authors.initials: A
authors.lastname: Kazemi
authors.forename: H
authors.initials: H
authors.lastname: Dargahi
authors.forename: T
authors.initials: T
authors.lastname: Bamedi
mesh_terms: D025901:Carboxypeptidase B2 / Q000235:genetics*; D016022:Case-Control Studies; D005177:Factor XIII Deficiency / Q000150:complications* / Q000235:genetics*; D005260:Female; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D020300:Intracranial Hemorrhages / Q000175:diagnosis / Q000209:etiology*; D008297:Male; D016017:Odds Ratio; D011110:Polymorphism, Genetic
chemical_list: D025901:Carboxypeptidase B2